Pathovacs Inc
CAGE Code: 5SAC3
NCAGE Code: 5SAC3
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 832427822
Summary
Pathovacs Inc is an Active Commercial Supplier with the Cage Code 5SAC3 and is tracked by Dun & Bradstreet under DUNS Number 832427822..
Address
1024 Roy J Carver Co
Lab I
Ames IA 50011-0001
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Championship Books And Video Ames Laboratory Songer Joseph Nebullam, Inc. Spanning Tree Technologies Inc Iowa State University Usai And Lab Supplies Inc Sigler Companies Inc. Sweetery Z, Llc American Radon Services Dba American North American Enterprise Olson Mfg Co Inc Engineering Development Corp Iowa State University American Blackwell Publishing Professional Telfax Communications Sauer-Sundstrand Iowa Engineers And Surveyors Supply Cim Technologies Corp Kapaun & Brown Inc
Frequently Asked Questions (FAQ) for CAGE 5SAC3
- What is CAGE Code 5SAC3?
- 5SAC3 is the unique identifier used by NATO Organizations to reference the physical entity known as Pathovacs Inc located at 1024 Roy J Carver Co, Lab I, Ames IA 50011-0001, United States.
- Who is CAGE Code 5SAC3?
- 5SAC3 refers to Pathovacs Inc located at 1024 Roy J Carver Co, Lab I, Ames IA 50011-0001, United States.
- Where is CAGE Code 5SAC3 Located?
- CAGE Code 5SAC3 is located in Ames, IA, USA.
Contracting History for CAGE 5SAC3 Most Recent 25 Records
- 75N91022C00027
- Pathovacs, Inc. Will Develop A Prototype In Vitro Diagnostic Device For Qualitative Screening Of Individuals For Anti-Hepatitis C Virus (Hcv) Antibodies To Determine Hcv Exposure.
- 28 Oct 2022
- Pathovacs, Inc. Will Develop A Prototype In Vitro Diagnostic Device For Qualitative Screening Of Individuals For Anti-Hepatitis C Virus (Hcv) Antibodies To Determine Hcv Exposure.
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $393,833.00
- Department Of Health And Human Services (Hhs)
- 75N91022C00027
- Pathovacs, Inc. Will Develop A Prototype In Vitro Diagnostic Device For Qualitative Screening Of Individuals For Anti-Hepatitis C Virus (Hcv) Antibodies To Determine Hcv Exposure.
- 20 Sep 2022
- Pathovacs, Inc. Will Develop A Prototype In Vitro Diagnostic Device For Qualitative Screening Of Individuals For Anti-Hepatitis C Virus (Hcv) Antibodies To Determine Hcv Exposure.
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $393,833.00
- Department Of Health And Human Services (Hhs)
- W911QY20C0114
- Sttr Phase Ii
- 4 Feb 2021
- Sttr Phase Ii
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $506,239.48
- Department Of Defense (Dod)
- W911QY20C0114
- Sttr Phase Ii
- 22 Feb 2023
- Sttr Phase Ii
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $975,605.67
- Department Of Defense (Dod)
- W911QY20C0114
- Sttr Phase Ii Project Extension Project Entitled: Circulating Diagnostic Markers Of Infectious Disease
- 23 Feb 2023
- Sttr Phase Ii Project Extension Project Entitled: Circulating Diagnostic Markers Of Infectious Disease
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $975,605.67
- Department Of Defense (Dod)
- W911QY20C0114
- Modification To Incremental Funding
- 29 Jul 2021
- Modification To Incremental Funding
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $975,605.67
- Department Of Defense (Dod)
- W911QY20C0114
- Sttr Phase Ii Project Extension Project Entitled: Circulating Diagnostic Markers Of Infectious Disease
- 1 Aug 2022
- Sttr Phase Ii Project Extension Project Entitled: Circulating Diagnostic Markers Of Infectious Disease
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $975,605.67
- Department Of Defense (Dod)
- W911QY20C0114
- Sttr Phase Ii
- 13 Mar 2023
- Sttr Phase Ii
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $975,605.67
- Department Of Defense (Dod)
- W911QY20C0114
- Sttr Phase Ii
- 31 Aug 2020
- Sttr Phase Ii
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $506,239.48
- Department Of Defense (Dod)
- W911QY20C0114
- Sttr Phase Ii
- 8 Jan 2021
- Sttr Phase Ii
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $506,239.48
- Department Of Defense (Dod)
- W911QY20C0114
- Sttr Phase Ii
- 29 Oct 2020
- Sttr Phase Ii
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $506,239.48
- Department Of Defense (Dod)
- W911QY18P0315
- Sttr Phase I
- 25 Sep 2018
- Sttr Phase I
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $149,503.95
- Department Of Defense (Dod)
- W911QY18P0315
- Sttr Phase I
- 20 Sep 2018
- Sttr Phase I
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $149,503.95
- Department Of Defense (Dod)
- W911QY18P0315
- Sttr Phase I
- 22 Jan 2019
- Sttr Phase I
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $149,503.95
- Department Of Defense (Dod)